Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioAegis Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
BioAegis Therapeutics

BioAegis Therapeutics

BioAegis Therapeutics develops biomarker treatments, restoring human protein levels to prevent inflammation.

HQ
North Brunswick, NJ, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

BioAegis Therapeutics, founded with a mission to combat inflammatory diseases, focuses on developing biomarker-directed treatments that restore depleted levels of plasma gelsolin, a natural human protein. This protein plays a crucial role in preventing the spread of inflammation, potentially averting multiple organ dysfunction syndrome. The company targets the healthcare industry, aiming to provide innovative solutions for conditions related to inflammation and infection.

Notable achievements include securing a $20 million BARDA DRIVe contract in October 2023 to advance treatments for Acute Respiratory Distress Syndrome (ARDS). BioAegis Therapeutics has made significant strides in clinical stages, leveraging its unique approach to harness innate immunity. The company's impactful work in restoring human protein levels has positioned it as a promising player in the field of inflammatory disease therapeutics.

BioAegis Therapeutics - Similar Companies

Elgia Therapeutics logo

Elgia Therapeutics

ProThera Biologics logo

ProThera Biologics

Aibios logo

Aibios

aibios.com

Therini Bio logo

Therini Bio

therinibio.com

Spyre Therapeutics logo

Spyre Therapeutics

aeglea.com

Quench Bio logo

Quench Bio

HI-Bio logo

HI-Bio

hibio.com

NeurAegis logo

NeurAegis

neuraegis.com

Bond Biosciences logo

Bond Biosciences

bond.bio

Aegle Therapeutics logo

Aegle Therapeutics

GEn1E Lifesciences logo

GEn1E Lifesciences

gen1e.com

Biomarck Pharmaceuticals logo

Biomarck Pharmaceuticals

Equillium logo

Equillium

equilliumbio.com

Biotheryx logo

Biotheryx

biotheryx.com

Palisade Bio logo

Palisade Bio

palisadebio.com

BioAegis Therapeutics - Quick Facts

Who are BioAegis Therapeutics' competitors?

Companies similar to BioAegis Therapeutics include Elgia Therapeutics, ProThera Biologics, Aibios and Therini Bio.

When was BioAegis Therapeutics founded?

BioAegis Therapeutics was founded in 2011.

Where is BioAegis Therapeutics' headquarters located?

BioAegis Therapeutics' headquarters is located in North Brunswick, NJ, US.

When was BioAegis Therapeutics' last funding round?

BioAegis Therapeutics' most recent funding round was for $22M (USD) in March 2022.

How much has BioAegis Therapeutics raised to-date?

As of Mar 22, 2022, BioAegis Therapeutics has raised a total of $42.3M (USD).

How many employees does BioAegis Therapeutics have?

BioAegis Therapeutics has 13 employees as of Feb 5, 2024.

BioAegis Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified